The agreement between BioNTech’s subsidiary BioNTech UK and the UK government is focused on accelerating clinical trials for ...

Olaparib tablets, marketed under the brand name Lynparza, are already available on the NHS for certain breast cancer ...

The struggle to make clinical trials easier to conduct and more attractive to patients while understanding the impact of ...

Science communication, together with creativity, ensures that information is both accurate and accessible. In order to ...

InnoPharma SRL is a full-service European Contract Research Organization (CRO) with over 17 years of extensive experience in Western and Eastern Europe. It has its headquarters near Milan, Italy and ...

We are the UK’s leading academic consultancy provider, connecting external organisations to the knowledge and resources of Imperial College London. Imperial College London is a world class university ...

Medscape Oncology is making a powerful impact at ASCO 2025, bringing seven high-impact symposia, new research insights, and ...

Regeneron Pharmaceuticals has announced that it will be acquiring human genetics and biotechnology company 23andMe for $256m.

AstraZeneca (AZ) has shared positive results from a phase 3b study of its anti-inflammatory reliever rescue therapy Airsupra ...

Medscape Education is proud to announce the presentation of eight innovative educational research publications at the ...

In exchange, 3SBio will receive $1.25bn upfront from Pfizer and will be eligible for certain development, regulatory and ...

Merck & Co – known as MSD outside of the US and Canada – has announced that its Welireg (belzutifan) has been approved by the ...